Scientists review the compliance of pharmacies and tobacco-selling policies, finding that Walgreens is the most likely to sell to minors.
Ketamine, a promising new treatment for depression, works through the brain's opioid system, Stanford study finds, defying long held beliefs.
Even substantial efforts in reducing opioid addiction, preventing overdoses and providing addiction treatment won't curb the crisis any time soon.
Stanford researchers examine the use of deep brain stimulation therapy to treat alcohol use disorders and reduce relapse rates.
How should physicians and parents communicate with teens about marijuana use? Stanford adolescent medicine expert Seth Ammerman, MD, offers advice.
There’s no good evidence for using marijuana for common complaints, and the products sold in cannabis dispensaries pose risks to kids and teens.
Exposure to 'third-hand smoke' — that is, the chemicals left behind on household surfaces after smoke has dissipated — increases the severity of asthma symptoms in mice. Stanford researchers are working to learn how this happens, and whether it might be possible to protect people with asthma from this exposure.
In a JAMA opinion piece, Gary Peltz and Tom Sudhof argue for policymakers and health leaders to combat opioid addictions early.
Howard Koh, MD, former assistant secretary of health in the Obama Administration, spoke recently in a Stanford Health Policy Forum discussion.
After his daughter died of a drug overdose, George Ting established the Esther Ting Memorial Professorship in Addiction Medicine at Stanford.
Researchers have studied the complex chemical composition of e-cigarette vapors to predict their health impacts on users and those around them.
Facebook prohibits paid tobacco advertising, but Stanford researchers found brands and vendors marketing their products through unpaid content, in apparent conflict with the rules or their spirit.
The Stanford-based Tobacco Prevention Toolkit offers a resource for educators and young people to learn about tobacco product use and their health.
Years into the opioid epidemic, Stanford psychiatrist and addiction researcher Anna Lembke cites signs of slow improvement and comments on benzodiazepines.
Stanford pain expert Beth Darnall discusses her clinical trials on methods to taper opioid doses for patients with chronic pain.
